Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024

Description:

Europe POCT Device Market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. – PowerPoint PPT presentation

Number of Views:29
Slides: 6
Provided by: PramodPatel
Category: Other

less

Transcript and Presenter's Notes

Title: Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024


1
Europe POCT Device Market
Europe POCT Device Market to Grow at a CAGR of
over 8.6 Through 2024
Europe POCT Device Market is expected to reach
USD 11.68bin 2016, at a CAGR of 8.6 in the
forecast period 2017 to 2024. The new market
report contains data for historic years 2015, the
base year of calculation is 2016 and the forecast
period is 2017 to 2024. Blood Glucose testing
kits market has the largest market segment in
Euope POCT device market.
Browse Full Report and Details
TOC https//databridgemarketresearch.com/reports/
europe-poct-device-market/
2
Report Description
The Europe POCT Device Market is highly
concentrated to a few big players and rest to
local players who cater to domestic markets only.
Roche dominated the Euope POCT device market
market accounting for the highest market share in
2016, followed by Siemens and Abbott. Other
players in this market include Alere Inc.,
Becton, Dickinson and Company, Johnson Johnson
Services Inc., PTS Diagnostics, Instrumentation
Laboratory, Nova Biomedical, Beckman Coulter,
Inc. among others holds 41.1 of the Europe POCT
device market in 2016.
Request For Free Sample Report
https//databridgemarketresearch.com/request-a-sa
mple/?dbmreurope-poct-device-market
3
Key Drivers
  • Rising cost of POCT devices is the factor which
    may hinder the growth of this market.
  • Many companies are making continuous efforts and
    advancesto make products more up to date, along
    with propelled innovations with reduced sample
    volume or less blood on portable devices. So as
    to create development for in-vitro diagnostics
    organizations in the market.
  • Emerging POCT device market as well as emergence
    of Microfluidic lab-on-a-chip technologieswill
    drive the market in future.

Speak to Expert https//databridgemarketresearch
.com/inquire-before-buying/?dbmreurope-poct-devic
e-market
4
Recent Developments
  • In May, 2017, Abbott announced CE Mark approval
    and its use of the new Rx Insertable Cardiac
    Monitor (ICM), which is the worlds first
    smartphone compatible ICM to identify or detect
    cardiac arrhythmias, including atrial
    fibrillation (AF), for therapy.
  • In May, 2017, Abbott announced the national
    reimbursement for freestyle Libre in France,
    providing access to revolutionary technology for
    people suffering with diabetes. This would help
    thousands of people to have access to test type 1
    and type 2 diabetes.

Request for Customization _at_ sopan.gedam_at_databridg
emarketresearch.com
5
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam1-888-387-2818 (Toll
Free) sopan.gedam_at_databridgemarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com